[go: up one dir, main page]

GB201415526D0 - Antibody Formulations - Google Patents

Antibody Formulations

Info

Publication number
GB201415526D0
GB201415526D0 GB201415526A GB201415526A GB201415526D0 GB 201415526 D0 GB201415526 D0 GB 201415526D0 GB 201415526 A GB201415526 A GB 201415526A GB 201415526 A GB201415526 A GB 201415526A GB 201415526 D0 GB201415526 D0 GB 201415526D0
Authority
GB
United Kingdom
Prior art keywords
antibody formulations
antibody
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201415526A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arecor Ltd
Original Assignee
Arecor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arecor Ltd filed Critical Arecor Ltd
Priority to GB201415526A priority Critical patent/GB201415526D0/en
Publication of GB201415526D0 publication Critical patent/GB201415526D0/en
Ceased legal-status Critical Current

Links

GB201415526A 2014-09-02 2014-09-02 Antibody Formulations Ceased GB201415526D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB201415526A GB201415526D0 (en) 2014-09-02 2014-09-02 Antibody Formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201415526A GB201415526D0 (en) 2014-09-02 2014-09-02 Antibody Formulations

Publications (1)

Publication Number Publication Date
GB201415526D0 true GB201415526D0 (en) 2014-10-15

Family

ID=51752500

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201415526A Ceased GB201415526D0 (en) 2014-09-02 2014-09-02 Antibody Formulations

Country Status (1)

Country Link
GB (1) GB201415526D0 (en)

Similar Documents

Publication Publication Date Title
IL252004A0 (en) Domain-exchanged antibody
IL250583A0 (en) Anti-tigit antibodies
IL250363A0 (en) Stable anti-il-4r-alpha antibody formulation
IL248802B (en) Antibody formulation
IL252422A0 (en) Effector-deficient anti-cd32a antibodies
IL251282A0 (en) Anti-il-7r antibody compositions
GB201411320D0 (en) Antibody construct
ZA201701461B (en) Antibody formulations
GB201410520D0 (en) Antibody
ZA201604640B (en) Novel anti-netrin-1 antibody
GB201419091D0 (en) Formulations
IL248220A0 (en) Anti-nme antibody
IL250374A0 (en) Anti-ceramide antibodies
GB201419261D0 (en) Formulations
SG11201700922YA (en) Anti-orai1 antibody
PL3112463T3 (en) Novel anti-presepsin antibody
GB201415526D0 (en) Antibody Formulations
GB201415298D0 (en) Antibody Formulations
GB201508257D0 (en) Antibody formulations
GB201418776D0 (en) Antibody
GB201413745D0 (en) Antibody
GB201411319D0 (en) Antibody
GB201407535D0 (en) Antibody Drug - Conjugates
GB201419092D0 (en) Anti-TIM-3 antibodies
GB201419089D0 (en) Anti-TIM-3 antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)